|
|
|
市場調査レポート
生体適合性材料市場の動向
Biocompatible Materials for the Human Body
| 発行 |
BCC Research |
| 出版日 |
2007年03月 |
商品コード |
50457 |
| ページ情報 |
英文 130 pages 26 tables |
| 価格 |
|
|
当商品の販売は、2011年08月08日を持ちまして終了しました。
Abstract
INTRODUCTION
A biocompatible material or a biomaterial is any natural or synthetic
substance that incorporates or integrates into a patient' s body. The role of
the biomaterial may be to perform, supplement, or replace a biological
function that is attenuated or lost.
The goal of this report is to assess the current market for biocompatible
materials including medical devices, tissue replacements, and surface coatings.
This report provides a complete overview of recent developments in each major
sector of the biomaterials market. It also outlines the significant medical
applications of each technology; the major market players; recent patents; and
emerging technologies in implantable medical devices, advanced tissue
replacements, and biocompatible surface coatings.
SCOPE OF STUDY
This report contains:
- An examination of the supporting products that have enhanced imaging at
the chemical level (reagents and contrast media) and at the analysis level
(software tools and image management)
- The U.S. markets for medical devices, tissue replacements, and surface
coating biomaterials for a variety of biomaterials categories including
metals, ceramics, polymers, and natural materials
- Assessment of the market for specific medical applications including
orthopedic surgery, cardiovascular surgery and care, wound management,
dentistry, urology, gastrointestinal surgery, ophthalmic care as well as
plastics and reconstructive surgery
- A review of important technology and a discussion of patents in the past
few decades
- Profiles of all the major companies in the industry.
INFORMATION SOURCES
This report has been assembled following an in-depth analysis of primary and
secondary data. Primary research was conducted via telephone interviews with
industry professionals, research scientists, physician-researchers, and
laboratory heads to discover the most recent developments in their fields of
interest. Secondary data was collected via a comprehensive search of the
scientific, peer-reviewed literature, clinical trial reports and databases,
industry trade media, company websites, annual reports, and industry press
releases.
The market assessments provided have been assembled based on publicly
available information from January 2002 up to and including January 2007. The
base year for this report is 2007 and forecast data are provided through 2012.
In many cases, figures for 2006 were not yet released and in these cases
figures were extrapolated from 2006 statistics, first quarter projections for
2007, and historical trends between 2002 and 2007. Market figures are based on
current (2007) dollars and inflation is not computed into the projection
figures.
ANALYST' S CREDENTIALS
Amy Brock, Ph.D. has over 10 years of research experience working at the
interface of the biological sciences, bioengineering, and biophysics. Trained
at the Massachusetts Institute of Technology and Harvard University, she holds
a B.S. and Ph.D. in biomedical science. She is the author of Pharmacogenomics:
New Technologies in the Development of Personalized Therapies, Kinase
Inhibitors and Genetic Diseases and Medical Imaging.
Table of Contents
- INTRODUCTIONSTUDY GOAL AND OBJECTIVES
- REASONS FOR DOING THE STUDY
- INTENDED AUDIENCE
- SCOPE OF REPORT
- INFORMATION SOURCES
- ANALYST' S CREDENTIALS
- RELATED BCC REPORTS
- BCC ONLINE SERVICES
- DISCLAIMER
- SUMMARY
- Summary Table:
- U.S. MARKET FORECAST FOR BIOCOMPATIBLE MATERIALS BY SEGMENT, THROUGH
2012 ($ MILLIONS)
- Summary Figure:
- U.S. MARKET FOR BIOCOMPATIBLE MATERIALS, BY SEGMENT 2004-2012 ($
MILLIONS)
- OVERVIEW
- INTRODUCTION TO BIOCOMPATIBLE MATERIALS
- TYPES OF MATERIALS
- Table 1 COMMON BIOCOMPATIBLE CERAMICS
- Table 2 COMMON BIOCOMPATIBLE METALS
- Table 3 COMMON BIOCOMPATIBLE POLYMERES
- NATURAL MATERIALS
- Collagen
- Chitosan
- Alginate
- Table 4 COMMON BIOCOMPATIBLE NATURAL MATERIALS
- TECHNOLOGY
- ADVANCES IN BIOACTIVE MATERIALS
- GROWTH FACTORS
- DRUG-ELUTING SURFACES
- HYDROGELS
- Hydrogels for Growth Factor Delivery
- Mechanoresponsive Hydrogels
- Poly(HEMA)
- DEGRADABLE OR BIORESORBABLE MATERIALS
- Chitosan
- Polyethylene Oxide
- Ethylene-vinyl Acetate
- THE CHALLENGES OF BIOCOMPATIBILITY
- BLOOD COMPATIBILITY AND PROTEIN ADSORPTION
- Albumin
- Immunoglobulins
- Fibrinogen
- CALCIFICATION
- INFECTION AND BIOFILMS
- HOST IMMUNE RESPONSE
- Wound Healing and Inflammation
- Foreign Body Immune Reaction and Rejection
- Complement Immune Response
- RECENT ADVANCES IN ENABLING TECHNOLOGIES
- BIOMIMETICS
- NANOTECHNOLOGY
- TISSUE ENGINEERING
- STEM CELLS
- BIOREACTOR TECHNOLOGY
- PATENT ANALYSIS
- PATENTS BY TECHNOLOGY
- Table 5 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY TECHNOLOGY, JANUARY
2006-JANUARY 2007
- Figure 1 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY TECHNOLOGY,
JANUARY 2006-JANUARY 2007 (%)
- PATENTS BY MEDICAL APPLICATION
- Table 6 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY MEDICAL
APPLICATION, JANUARY 2006-JANUARY 2007
- Figure 2 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY MEDICAL
APPLICATION, JANUARY 2006-JANUARY 2007 (%)
- PATENTS BY REGION/OR COUNTRY (DEPENDING ON DISTRIBUTION)
- Table 7 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY REGION, JANUARY
2006-JANUARY 2007
- Figure 3 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY COUNTRY, JANUARY
2006-JANUARY 2007 (%)
- PATENTS BY ASSIGNEE
- Table 8 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY ASSIGNEE
AFFILIATION, JANUARY 2006-JANUARY 2007
- Figure 4 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY ASSIGNEE
AFFILIATION, JANUARY 2006-JANUARY 2007 (%)
- Table 9 BIOCOMPATIBLE MATERIALS ISSUED PATENTS BY ASSIGNEE, JANUARY
2006-JANUARY 2007
- Table 9 (CONTINUED)
- Table 9 (CONTINUED)
- Table 9 (CONTINUED)
- Table 9 (CONTINUED)
- PATENTS OF INTEREST
- Patent Title: Triggered Release Hydrogel Drug Delivery System
- Patent Title: Adaptive Memory Prioritization for Implanted Medical
Devices
- Patent Title: Coumarin Endcapped Absorbable Polymers
- Bioabsorbable Polymeric Implants and a Method Of Using The Same to
Create Occlusions
- SPECIAL ISSUES IN CARDIAC STENT PATENTING
- Special Issues in Cardiac ...(Continued)
- GOVERNMENT REGULATION
- FDA REGULATION OF MEDICAL DEVICES
- BIOMATERIALS ACCESS ASSURANCE ACT OF 1998
- REGULATION OF TISSUE ENGINEERED PRODUCTS
- FDA REGULATION OF GOOD TISSUE PRACTICES
- GOVERNMENT REGULATION OF NANOMATERIALS
- NEW FDA APPROVALS
- Novel Hernia Repair Material
- Low Pressure Perfusion Catheter
- Real-Time Continuous Glucose Monitor
- Omega-3 Fatty Acid Coated Mesh
- Wireless Telemetry and Cardiac Rhythm Management Implants
- Wireless Telemetry ... (Continued)
- MARKET FOR BIOCOMPATIBLE MATERIALS
- Table 10 U.S. MARKET FORECAST FOR BIOCOMPATIBLE MATERIALS BY SEGMENT,
THROUGH 2012 ($ MILLIONS)
- IMPLANTABLE MEDICAL DEVICES
- Table 11 U.S. MARKET FORECAST FOR IMPLANTABLE MEDICAL DEVICES BY
SEGMENT, THROUGH 2012 ($ MILLIONS)
- Figure 5 U.S. MARKET FOR IMPLANTABLE MEDICAL DEVICES, BY SEGMENT
2004-2012 ($ MILLIONS)
- Table 12 U.S. MARKET FORECAST FOR TISSUE REPLACEMENTS BY SEGMENT,
THROUGH 2012 ($ MILLIONS)
- Table 12 (CONTINUED)
- Figure 6 U.S. MARKET FOR TISSUE REPLACEMENTS, BY SEGMENT 2004-2012 ($
MILLIONS)
- Table 13 U.S. MARKET FORECAST FOR BIOCOMPATIBLE SURFACE COATINGS BY
SEGMENT, THROUGH 2012 ($ MILLIONS)
- Figure 7 U.S. MARKET FOR BIOCOMPATIBLE SURFACE COATINGS BY SEGMENT,
2004-2012 ($ MILLIONS)
- SURFACE COATINGS (CONTINUED)
- U.S. MARKET FOR BIOMATERIALS, BY APPLICATION
- Table 14 U.S. MARKET FORECAST FOR BIOMATERIALS BY APPLICATION, THROUGH
2012 ($ MILLIONS)
- Figure 8 U.S. MARKET FOR BIOMATERIALS, BY MEDICAL APPLICATION 2004-2012
($ MILLIONS)
- Table 15 U.S. MARKET FOR ORTHOPEDIC BIOMATERIALS, BY SEGMENT THROUGH
2012 ($ MILLIONS)
- Figure 9 U.S. MARKET FOR ORTHOPEDIC BIOMATERIALS, BY SEGMENT, 2004-2012
($ MILLIONS)
- BONE-PLATE MATERIALS
- Bone-Plate Materials (Continued)
- HIP REPLACEMENTS
- Hip Resurfacing
- KNEE REPLACEMENTS
- Non-constrained Implants
- Semi-constrained Implants
- Constraint or Hinged Implants
- Unicondylar Knee Replacement
- SPINAL IMPLANTS
- Types of Spinal Implants
- Disc Arthroplasty
- THE MARKET FOR ORTHOPEDIC BIOMATERIALS
- CARDIOVASCULAR APPLICATIONS
- Table 16 U.S. MARKET FORECAST FOR CARDIOVASCULAR BIOMATERIALS BY
SEGMENT, THROUGH 2012 ($ MILLIONS)
- CARDIAC PACEMAKERS
- IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
- Implantable Cardioverter ... (Continued)
- CARDIAC STENTS
- Metal Stents
- Drug-Eluting Stents (DES)
- Rapamycin and Related Immunosuppressants
- Paclitaxel
- Drug-Eluting Stents And Complications
- HEART VALVES
- VASCULAR ACCESS DEVICES
- Peripherally Inserted Central Catheter (PICC)
- Tunneled Catheter
- Subcutaneous Port
- PERIPHERAL VASCULAR GRAFTS
- Figure 10 U.S. MARKET FOR CARDIOVASCULAR BIOMATERIALS, BY SEGMENT
2004-2012 ($ MILLIONS)
- WOUND MANAGEMENT APPLICATIONS
- Table 17 U.S. MARKET FORECAST FOR WOUND MANAGEMENT BIOMATERIALS BY
SEGMENT, THROUGH 2012 ($ MILLIONS)
- Figure 11 U.S. MARKET FOR WOUND MANAGEMENT BIOMATERIALS BY SEGMENT,
2004-2012 ($ MILLIONS)
- TISSUE SEALANTS AND HEMOSTATS
- Bovine Serum/ Albumin/ Glutaraldehyde
- Fibrin
- Gelatin Matrix/ Thrombin Sealants
- Polyethylene Glycol Hydrogels
- ADHESION BARRIERS
- Table 18 TYPES OF ADHESION BARRIERS AND MANUFACTURERS
- SKIN SUBSTITUTES
- Skin Substitutes (Continued)
- Table 19 MAJOR SKIN SUBSTITUTE PRODUCTS
- Skin Substitutes (Continued)
- Genetically Modified Skin Cells
- GASTROINTESTINAL APPLICATIONS
- Table 20 U.S. MARKET FORECAST FOR GASTROINTESTINAL BIOMATERIALS BY
SEGMENT, THROUGH 2012 ($ MILLIONS)
- Figure 12 U.S. MARKET FOR GASTROINTESTINAL BIOMATERIALS, BY SEGMENT,
2004-2012 ($ MILLIONS)
- Table 21 U.S. MARKET FORECAST FOR UROLOGY BIOMATERIALS BY SEGMENT,
THROUGH 2012 ($ MILLIONS)
- URETERAL STENTS
- URETHRAL STENTS
- URINARY CATHETERS
- Removal
- Resistance to Encrustation
- Biofilms
- Figure 13 U.S. MARKET FOR UROLOGY BIOMATERIALS BY SEGMENT, 2004-2012 ($
MILLIONS)
- THE MARKET FOR UROLOGY BIOMATERIALS
- Table 22 U.S. MARKET FORECAST FOR PLASTIC SURGERY BIOMATERIALS BY SEGMENT,
THROUGH 2012 ($ MILLIONS)
- BREAST IMPLANTS
- Saline-Filled Implants
- Silicone Gel Implants
- Safety Considerations
- Breakage and Leakage
- Breakage and Leakage (Continued)
- Scarring
- Platinum
- INJECTABLE FILLERS
- Zyderm and Zyplast Collagen
- Fibrel
- Artecoll
- Hylan B Gel
- Resoplast
- Autologen
- Isolagen
- Dermalogen
- AlloDerm
- Fat Injections
- Table 23 COLLAGEN FILLERS
- FACIAL IMPLANTS
- Teflon
- Polyethylene
- Hydroxyapatite
- Figure 14 U.S. MARKET FOR PLASTIC SURGERY BIOMATERIALS, BY SEGMENT
2004-2012 ($ MILLIONS)
- THE MARKET FOR PLASTIC SURGERY BIOMATERIALS
- The Market for Plastic ... (Continued)
- ON THE HORIZON
- BIOMATERIALS FOR GENE AND PROTEIN DELIVERY
- ELECTROSPINNING SCAFFOLDS
- COMPANY PROFILES
- ABIOMED, INC
- ADVANCED BIONICS CORPORATION
- ALLERGAN INC.
- BAXTER INTERNATONAL INC.
- BIOINTERACTIONS LTD.
- BIOMET, INC
- COCHLEAR CORPORATION
- CONMED CORPORATION
- DEPUY ORTHOPAEDICS, INC.
- ENCORE ORTHOPEDICS
- GUIDANT CORP.
- INTERPORE CROSS INTERNATIONAL
- JOHNSON & JOHNSON MEDICAL, INC
- MEDICAL ELECTRONICS (MED-EL)
- MEDTRONIC, INC.
- MENTOR CORPORATION
- MIV THERAPEUTICS
- SOFAMOR DANEK GROUP
- STAAR SURGICAL COMPANY
- STRYKER CORPORATION
- SULZER MEDICA
- SULZER MEDICA (CONTINUED)
- SYNTHES CORPORATION
- THORATEC LABORATORIES
- ZIMMER CORP.
- MARKET SHARE
- MARKET SHARE OF MAJOR COMPANIES' IMPLANTABLE MEDICAL DEVICES
- Table 24 MARKET SHARE OF MAJOR COMPANIES' IMPLANTABLE MEDICAL DEVICES (%)
- Figure 15 MARKET SHARE OF MAJOR COMPANIES IN IMPLANTABLE MEDICAL DEVICES
(%)
- MARKET SHARE OF MAJOR COMPANIES IN TISSUE REPLACEMENTS BIOMATERIALS
- Table 25 MARKET SHARE OF MAJOR COMPANIES IN TISSUE REPLACEMENTS (%)
- Figure 16 MARKET SHARE OF MAJOR COMPANIES IN TISSUE REPLACEMENTS (%)
- MARKET SHARE OF MAJOR COMPANIES IN SURFACE COATINGS
- Table 26 MARKET SHARE OF MAJOR COMPANIES IN SURFACE COATINGS (%)
- Figure 17 MARKET SHARE OF MAJOR COMPANIES IN SURFACE COATINGS (%)
- LIST OF TABLES
- Summary Table:
- U.S. MARKET FORECAST FOR BIOCOMPATIBLE MATERIALS BY SEGMENT, THROUGH
2012 ($ MILLIONS)
- Table 1 COMMON BIOCOMPATIBLE CERAMICS
- Table 2 COMMON BIOCOMPATIBLE METALS
- Table 3 COMMON BIOCOMPATIBLE POLYMERES
- Table 4 COMMON BIOCOMPATIBLE NATURAL MATERIALS
- Table 5 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY TECHNOLOGY, JANUARY
2006-JANUARY 2007
- Table 6 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY MEDICAL APPLICATION,
JANUARY 2006-JANUARY 2007
- Table 7 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY REGION, JANUARY
2006-JANUARY 2007
- Table 8 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY ASSIGNEE AFFILIATION,
JANUARY 2006-JANUARY 2007
- Table 9 BIOCOMPATIBLE MATERIALS ISSUED PATENTS BY ASSIGNEE, JANUARY
2006-JANUARY 2007
- Table 10 U.S. MARKET FORECAST FOR BIOCOMPATIBLE MATERIALS BY SEGMENT,
THROUGH 2012 ($ MILLIONS)
- Table 11 U.S. MARKET FORECAST FOR IMPLANTABLE MEDICAL DEVICES BY
SEGMENT, THROUGH 2012 ($ MILLIONS)
- Table 12 U.S. MARKET FORECAST FOR TISSUE REPLACEMENTS BY SEGMENT,
THROUGH 2012 ($ MILLIONS)
- Table 13 U.S. MARKET FORECAST FOR BIOCOMPATIBLE SURFACE COATINGS BY
SEGMENT, THROUGH 2012 ($ MILLIONS)
- Table 14 U.S. MARKET FORECAST FOR BIOMATERIALS BY APPLICATION, THROUGH
2012 ($ MILLIONS)
- Table 15 U.S. MARKET FOR ORTHOPEDIC BIOMATERIALS, BY SEGMENT THROUGH
2012 ($ MILLIONS)
- Table 16 U.S. MARKET FORECAST FOR CARDIOVASCULAR BIOMATERIALS BY
SEGMENT, THROUGH 2012 ($ MILLIONS)
- Table 17 U.S. MARKET FORECAST FOR WOUND MANAGEMENT BIOMATERIALS BY
SEGMENT, THROUGH 2012 ($ MILLIONS)
- Table 18 TYPES OF ADHESION BARRIERS AND MANUFACTURERS
- Table 19 MAJOR SKIN SUBSTITUTE PRODUCTS
- Table 20 U.S. MARKET FORECAST FOR GASTROINTESTINAL BIOMATERIALS BY
SEGMENT, THROUGH 2012 ($ MILLIONS)
- Table 21 U.S. MARKET FORECAST FOR UROLOGY BIOMATERIALS BY SEGMENT,
THROUGH 2012 ($ MILLIONS)
- Table 22 U.S. MARKET FORECAST FOR PLASTIC SURGERY BIOMATERIALS BY
SEGMENT, THROUGH 2012 ($ MILLIONS)
- Table 23 COLLAGEN FILLERS
- Table 24 MARKET SHARE OF MAJOR COMPANIES' IMPLANTABLE MEDICAL DEVICES (%)
- Table 25 MARKET SHARE OF MAJOR COMPANIES IN TISSUE REPLACEMENTS (%)
- Table 26 MARKET SHARE OF MAJOR COMPANIES IN SURFACE COATINGS (%)
- LIST OF FIGURES
- Summary Figure:
- U.S. MARKET FOR BIOCOMPATIBLE MATERIALS, BY SEGMENT 2004-2012 ($
MILLIONS)
- Figure 1 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY TECHNOLOGY, JANUARY
2006-JANUARY 2007 (%)
- Figure 2 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY MEDICAL APPLICATION,
JANUARY 2006-JANUARY 2007 (%)
- Figure 3 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY COUNTRY, JANUARY
2006-JANUARY 2007 (%)
- Figure 4 BIOCOMPATIBLE MATERIALS, ISSUED PATENTS BY ASSIGNEE
AFFILIATION, JANUARY 2006-JANUARY 2007 (%)
- Figure 5 U.S. MARKET FOR IMPLANTABLE MEDICAL DEVICES, BY SEGMENT
2004-2012 ($ MILLIONS)
- Figure 6 U.S. MARKET FOR TISSUE REPLACEMENTS, BY SEGMENT 2004-2012 ($
MILLIONS)
- Figure 7 U.S. MARKET FOR BIOCOMPATIBLE SURFACE COATINGS BY SEGMENT,
2004-2012 ($ MILLIONS)
- Figure 8 U.S. MARKET FOR BIOMATERIALS, BY MEDICAL APPLICATION 2004-2012
($ MILLIONS)
- Figure 9 U.S. MARKET FOR ORTHOPEDIC BIOMATERIALS, BY SEGMENT, 2004-2012
($ MILLIONS)
- Figure 10 U.S. MARKET FOR CARDIOVASCULAR BIOMATERIALS, BY SEGMENT
2004-2012 ($ MILLIONS)
- Figure 11 U.S. MARKET FOR WOUND MANAGEMENT BIOMATERIALS BY SEGMENT,
2004-2012 ($ MILLIONS)
- Figure 12 U.S. MARKET FOR GASTROINTESTINAL BIOMATERIALS, BY SEGMENT,
2004-2012 ($ MILLIONS)
- Figure 13 U.S. MARKET FOR UROLOGY BIOMATERIALS BY SEGMENT, 2004-2012 ($
MILLIONS)
- Figure 14 U.S. MARKET FOR PLASTIC SURGERY BIOMATERIALS, BY SEGMENT
2004-2012 ($ MILLIONS)
- Figure 15 MARKET SHARE OF MAJOR COMPANIES IN IMPLANTABLE MEDICAL DEVICES
(%)
- Figure 16 MARKET SHARE OF MAJOR COMPANIES IN TISSUE REPLACEMENTS (%)
- Figure 17 MARKET SHARE OF MAJOR COMPANIES IN SURFACE COATINGS (%)
|
 |
